401 related articles for article (PubMed ID: 10588632)
1. Reversal of human neutrophil survival by leukotriene B(4) receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors.
Lee E; Lindo T; Jackson N; Meng-Choong L; Reynolds P; Hill A; Haswell M; Jackson S; Kilfeather S
Am J Respir Crit Care Med; 1999 Dec; 160(6):2079-85. PubMed ID: 10588632
[TBL] [Abstract][Full Text] [Related]
2. Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals.
Lee E; Robertson T; Smith J; Kilfeather S
Am J Respir Crit Care Med; 2000 Jun; 161(6):1881-6. PubMed ID: 10852761
[TBL] [Abstract][Full Text] [Related]
3. Activation of leukotriene synthesis in human neutrophils by exogenous arachidonic acid: inhibition by adenosine A(2a) receptor agonists and crucial role of autocrine activation by leukotriene B(4).
Surette ME; Krump E; Picard S; Borgeat P
Mol Pharmacol; 1999 Nov; 56(5):1055-62. PubMed ID: 10531413
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte-macrophage colony-stimulating factor increases the synthesis of leukotriene B4 by human neutrophils in response to platelet-activating factor. Enhancement of both arachidonic acid availability and 5-lipoxygenase activation.
McColl SR; Krump E; Naccache PH; Poubelle PE; Braquet P; Braquet M; Borgeat P
J Immunol; 1991 Feb; 146(4):1204-11. PubMed ID: 1846895
[TBL] [Abstract][Full Text] [Related]
5. Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils.
McDonald PP; McColl SR; Braquet P; Borgeat P
Br J Pharmacol; 1994 Mar; 111(3):852-60. PubMed ID: 8019762
[TBL] [Abstract][Full Text] [Related]
6. Role of 5-lipoxygenase pathway in the regulation of RAW 264.7 macrophage proliferation.
Nieves D; Moreno JJ
Biochem Pharmacol; 2006 Oct; 72(8):1022-30. PubMed ID: 16934759
[TBL] [Abstract][Full Text] [Related]
7. Itraconazole-mediated inhibition of calcium entry into platelet-activating factor-stimulated human neutrophils is due to interference with production of leukotriene B4.
Steel HC; Tintinger GR; Theron AJ; Anderson R
Clin Exp Immunol; 2007 Oct; 150(1):144-50. PubMed ID: 17683509
[TBL] [Abstract][Full Text] [Related]
8. Role of leukotrienes in the regulation of human granulocyte behaviour: dissociation between agonist-induced activation and retardation of apoptosis.
Murray J; Ward C; O'Flaherty JT; Dransfield I; Haslett C; Chilvers ER; Rossi AG
Br J Pharmacol; 2003 May; 139(2):388-98. PubMed ID: 12770944
[TBL] [Abstract][Full Text] [Related]
9. Induction by chemokines of lipid mediator synthesis in granulocyte-macrophage colony-stimulating factor-treated human neutrophils.
McDonald PP; Pouliot M; Borgeat P; McColl SR
J Immunol; 1993 Dec; 151(11):6399-409. PubMed ID: 8245474
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte/macrophage colony-stimulating factor stimulates the expression of the 5-lipoxygenase-activating protein (FLAP) in human neutrophils.
Pouliot M; McDonald PP; Borgeat P; McColl SR
J Exp Med; 1994 Apr; 179(4):1225-32. PubMed ID: 8145039
[TBL] [Abstract][Full Text] [Related]
11. The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5-lipoxygenase products.
Fischer L; Hornig M; Pergola C; Meindl N; Franke L; Tanrikulu Y; Dodt G; Schneider G; Steinhilber D; Werz O
Br J Pharmacol; 2007 Oct; 152(4):471-80. PubMed ID: 17704828
[TBL] [Abstract][Full Text] [Related]
12. Modulation of leukotriene B4 receptor-1 expression by dexamethasone: potential mechanism for enhanced neutrophil survival.
Stankova J; Turcotte S; Harris J; Rola-Pleszczynski M
J Immunol; 2002 Apr; 168(7):3570-6. PubMed ID: 11907121
[TBL] [Abstract][Full Text] [Related]
13. Effects of the 5-lipoxygenase activating protein inhibitor MK886 on voltage-gated and Ca2+-activated K+ currents in rat arterial myocytes.
Smirnov SV; Knock GA; Aaronson PI
Br J Pharmacol; 1998 Jun; 124(3):572-8. PubMed ID: 9647483
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of platelet-activating factor-induced leukotriene synthesis in neutrophils by granulocyte-macrophage colony-stimulating factor (GM-CSF): studies on the mechanism of action of GM-CSF.
McColl SR; Krump E; McDonald PP; Braquet M; Naccache PH; Borgeat P
J Lipid Mediat; 1990; 2 Suppl():S119-27. PubMed ID: 1966811
[TBL] [Abstract][Full Text] [Related]
15. Human granulocyte-macrophage colony-stimulating factor and other cytokines prime human neutrophils for enhanced arachidonic acid release and leukotriene B4 synthesis.
DiPersio JF; Billing P; Williams R; Gasson JC
J Immunol; 1988 Jun; 140(12):4315-22. PubMed ID: 2453577
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic 5-lipoxygenase activity is required for neutrophil responsivity.
Guidot DM; Repine MJ; Westcott JY; Repine JE
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8156-9. PubMed ID: 8058773
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils.
Coffey MJ; Phare SM; George S; Peters-Golden M; Kazanjian PH
J Clin Invest; 1998 Aug; 102(4):663-70. PubMed ID: 9710433
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of the 5-lipoxygenase pathway in atherosclerosis.
Bäck M
Curr Pharm Des; 2009; 15(27):3116-32. PubMed ID: 19754386
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the expression of 5-lipoxygenase-activating protein/5-lipoxygenase and the synthesis of leukotriene B(4) in osteoarthritic chondrocytes: role of transforming growth factor beta and eicosanoids.
Martel-Pelletier J; Mineau F; Fahmi H; Laufer S; Reboul P; Boileau C; Lavigne M; Pelletier JP
Arthritis Rheum; 2004 Dec; 50(12):3925-33. PubMed ID: 15593193
[TBL] [Abstract][Full Text] [Related]
20. Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: a role for transcellular biosynthesis of cysteinyl-leukotrienes.
Di Gennaro A; Carnini C; Buccellati C; Ballerio R; Zarini S; Fumagalli F; Viappiani S; Librizzi L; Hernandez A; Murphy RC; Constantin G; De Curtis M; Folco G; Sala A
FASEB J; 2004 May; 18(7):842-4. PubMed ID: 15001558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
